Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — December 2025

Genmab — December 2025

Planlagt Fastgjort Låst Flyttet Genmab
217 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bibob
    wrote on sidst redigeret af
    #45

    God morgen. 🙂

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #46

      December 7, 2025
      EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma https://www.ajmc.com/view/epcore-fl-1-adding-epcoritamab-to-r2-delivers-new-benchmark-in-second-line-follicular-lymphoma

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #47

        Genmab : Leerink Partners Raises Target Price to $38 From $34 8-12-2025

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #48

          Genmab gør et godt helhedsindtryk med sine studiedata mener Jyske Bank https://proinvestor.com/investornyt/1390946/genmab-gor-et-godt-helhedsindtryk-med-sine-studiedata-mener-jyske-bank

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #49

            RedirecTT-1 Talquetamab (GPRC5D) + Teclistamab (BCMA) - Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab - https://www.nejm.org/doi/full/10.1056/NEJMoa2514752 https://x.com/DrRishabhOnco/status/1997930035827929089

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #50

              for those that didn't read genmab's press release, the FL data was also published in the Lancet - Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02360-8/fulltext

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #51

                Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT) https://proinvestor.com/investornyt/1391260/genmab-announces-new-data-from-phase-1b-2-epcore-cll-1-highlighting-potential-of-epcoritamab-as-monotherapy-and-in-combination-for-patients-with-richter-transformation-rt

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #52

                  Genmabs kræftmiddel viser opmuntrende resultater mod Richter transformation https://proinvestor.com/investornyt/1391335/genmabs-kraeftmiddel-viser-opmuntrende-resultater-mod-richter-transformation

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #53

                    Tak Helge og PN og god morgen:-)

                    1 Reply Last reply
                    0
                    • T Offline
                      T Offline
                      transalp
                      wrote on sidst redigeret af
                      #54

                      Også tak og go morgen, herfra.. 🙂

                      1 Reply Last reply
                      0
                      • StockBullS Offline
                        StockBullS Offline
                        StockBull
                        wrote on sidst redigeret af
                        #55

                        God morgen - Genmab ser ud til at gå op eller sidelæns-op de kommende uger, ingen klar korrektionsrisiko fra RSI lige nu. Positivt efter ASH-data.

                        1 Reply Last reply
                        0
                        • StockBullS Offline
                          StockBullS Offline
                          StockBull
                          wrote on sidst redigeret af
                          #56

                          RSI(14) på dagsgrafen er ca. 55-56 (ikke over 70). TA peger stadig på opadgående bias på kort sigt (strong buy på moving averages, stigende trendkanal).

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #57

                            Just a moment...

                            favicon

                            (proinvestor.com)

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #58

                              #ASH25 | PRESENTATION
                              Philip Thompson,
                              @MDAndersonNews

                              @PeterMacCC
                              , presents first results of epcoritamab + lenalidomide (Arm 2B; N = 11) and epcoritamab + R-CHOP (Arm 2C; N = 30) in patients with Richter transformation from the phase Ib/II EPCORE CLL-1 trial. https://x.com/lymphomahub/status/1998150848279609470

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #59

                                Xian Deng
                                UBS Buy Kr.2,700.00 Maintained 8-12-25

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  Bullish
                                  wrote on sidst redigeret af
                                  #60

                                  Tak, @
                                  Stockbull, perfekt timing- jeg har solgt en andel, og overvejer, om det er nu jeg skal samle op igen

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raun
                                    wrote on sidst redigeret af
                                    #61

                                    Håber som altid Stockbull har ret i sin TA. Men jeg har virkelig svært ved at få øje på at vi er i en uptrend.... - Det ligner for mig meget mere en skruetvinge og det kan TA ikke gøre noget ved.

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      Bullish
                                      wrote on sidst redigeret af
                                      #62

                                      Jeg købte halvdelen i dag, den kan jo også pludselig stikke af opad. Tror jeg venter og ser om jeg ikke kan få lidt mere rabat på de sidste..

                                      1 Reply Last reply
                                      0
                                      • StockBullS Offline
                                        StockBullS Offline
                                        StockBull
                                        wrote on sidst redigeret af
                                        #63

                                        Jeg tror nu, Jan formår at løfte aktien pænt på torsdagens R&D Update & ASH Data Review. Hvis markedet begynder at prise forventningerne ind allerede i morgen er det her et attraktivt dip man udnytte hvis man tror på Jan og pipelinen.

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #64

                                          Mulig US rentenedsættelse imo er normalt også guf for biotech aktierne . Så ned idag og op onsdag, torsdag og fredag (måske)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper